Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UVision360 is best known for its LUMINELLE DTx Hysteroscopy System, an office-based, high-precision diagnostic and therapeutic gynecologic device that enables minimally invasive procedures and cystoscopy. It offers OR-level optics at a lower cost, targets female reproductive health, and provides an alternative to hospital-based hysteroscopy with strong cost and clinical advantages. The system is FDA cleared and used clinically for gynecologic indications including abnormal uterine bleeding, polyps, and cancer screening, with novel features such as real-time, visually guided biopsy. The LUMINELLE Bx system further expands its biopsy capabilities. UVision360 was acquired by Caldera Medical in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UVision360.